Professional Advisory Board

Barry Bultz, PhD
Professor and Head, Division of Psychosocial Oncology, Daniel Family Leadership Chair in Psychosocial Oncology, Cumming School of Medicine, University of Calgary, Dept of Psychosocial Oncology, Tom Baker Cancer Centre

Stephanie Cohen, MS, LCGC
Genetic Counselor, Ascension St. Vincent

Sanja Dacic, MD, PhD
Director of Pathology, University of Pittsburgh Medical Center

Christina M. Dieli-Conwright, PhD, MPH, FACSM
Physiologist, Dana-Farber Cancer Institute, Harvard Medical School

Bruce Edelen
Oncology Reimbursement Specialist, Oncology Reimbursement Management Inc.

Stephen Edge, MD
Surgical Oncologist, Roswell Park Comprehensive Cancer Center

Mary Lou Galantino, PT, MS, PhD, MSCE, FNAP, FAPTA
Distinguished Professor of Physical Therapy, Stockton University

Ashley Haggerty, MD, MSCE
Medical Director of Gynecologic Oncology, Riverview Medical Center

Karen Hurley, PhD
Clinical Psychologist and Hereditary Cancer Risk Specialist, Cleveland Clinic

Rupesh Kotecha, MD
Chief of Radiosurgery, Miami Cancer Institute

Thomas W. LeBlanc, MD, MA, MHS, FAAHPM
Blood Cancers Specialist, Duke University School of Medicine

Sharyn Lewin, MD
GYN Cancers Specialist, Holy Name Medical Center

John Marshall, MD
Director, The Ruesch Center for the Cure of GI Cancers, Frederick P Smith Endowed Chair, Chief, Hematology and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center

Michele McCorkle, RN, MSN
Sr. Director, Clinical Data Services, Vidence

Mark A. O'Rourke, MD
Integrative Oncology, Co-chair, Palliative & EOL Care Committee, SWOG Cancer Research Network, Prisma Health Upstate Cancer Institute

Kristi Orbaugh, RN, MSN, RNP, AOCN
Oncology Nurse, Community Hospital Oncology Physicians

Kathryn Schmitz, PhD, MPH
Distinguished Professor of Public Health Sciences, Penn State College of Medicine

Neal Shore, MD
GU Cancers Specialist, Atlantic Urology Clinics

Christopher Spevak, MD, MPH, JD
Georgetown University Medical Center, Professor of Anesthesiology

John Sprandio Sr., MD
Hematology/Oncology, Main Line Health

Yousuf Zafar, MD, MHS, FASCO
Chief Quality & Innovation Officer, Associate Professor of Medicine, Public Policy, and Population Science, Duke Cancer Institute